{"page":{"totalFilteredElements":11},"studies":[{"active":true,"description":"Verbesserung der Versorgungsqualität durch standardisierte Dokumentation d-uo VERSUS","eudractNumber":null,"id":10722,"indications":[{"id":"uro","name":"Urogenitale Tumoren (Niere, ableitende Harnwege, Hoden)"},{"id":"uro1","name":"Nierenzellkarzinom"},{"id":"uro2","name":"Tumoren der ableitenden Harnwege (Nierenbecken, Ureter, Harnblase, Harnröhre)"},{"id":"uro3","name":"Hodenkarzinom"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2024-11-11T10:24:40+01:00","shortTitle":"Versus","therapeutical":false,"therapyLines":[{"id":"tl_5","name":"N/A"}]}]}